These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12487173)

  • 21. The co-existence of Fabry and celiac diseases: a case report.
    Tümer L; Ezgü FS; Hasanoğlu A; Dalgiç B; Bakkaloğlu SA; Memiş L; Dursun A
    Pediatr Nephrol; 2004 Jun; 19(6):679-81. PubMed ID: 15085421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease.
    Prabakaran T; Birn H; Bibby BM; Regeniter A; Sørensen SS; Feldt-Rasmussen U; Nielsen R; Christensen EI
    Nephrol Dial Transplant; 2014 Mar; 29(3):619-25. PubMed ID: 24215016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membranous nephropathy without vacuolated podocytes in Fabry disease treated with agalsidase-β and carbamazepine: A case report.
    Kanai T; Ito T; Aoyagi J; Yamagata T
    Medicine (Baltimore); 2022 Feb; 101(7):e28830. PubMed ID: 35363176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renal involvement in Fabry disease].
    Kaaroud H; Béji S; Boubaker K; Ben Moussa F; Ben Hamida F; Goucha R; Ben Dridi MF; Ben Turkia H; Kheder A
    Tunis Med; 2007 Mar; 85(3):240-3. PubMed ID: 17668583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria.
    Tøndel C; Kanai T; Larsen KK; Ito S; Politei JM; Warnock DG; Svarstad E
    Nephron; 2015; 129(1):16-21. PubMed ID: 25531941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fabry disease. A case report.
    Kotnik J; Kotnik F; Desnick RJ
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):15-9. PubMed ID: 15818441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A possible case of carbamazepine-induced renal phospholipidosis mimicking Fabry disease.
    Chen J; Bai L; He Y
    Clin Exp Nephrol; 2022 Mar; 26(3):303-304. PubMed ID: 35059891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fabry nephropathy in a female with superposed IgA glomerulonephritis].
    Pisani A; Sessa A; Sabbatini M; Andreucci MV; Fusco C; Balletta M; Cianciaruso B
    G Ital Nefrol; 2005; 22(4):385-9. PubMed ID: 16267800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subclinical Fabry's disease occurring in the context of IgA nephropathy.
    Kawamura O; Sakuraba H; Itoh K; Suzuki Y; Doi M; Kuwabara H; Oshima S; Abe S; Warabi H; Yoshizawa N
    Clin Nephrol; 1997 Feb; 47(2):71-5. PubMed ID: 9049452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of Fabry's disease.
    Miura M; Tomino Y; Inoue W; Endoh M; Suga T; Kaneshige H; Nomoto Y; Sakai H; Matsuo I; Nagura H; Ikeda N
    Tokai J Exp Clin Med; 1983 Jan; 8(1):23-9. PubMed ID: 6310828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel α-Galactosidase A Mutation (K391E) in a Young Woman With Severe Cardiac and Renal Manifestations of Fabry Disease.
    Wakakuri H; Nakamura S; Utsumi K; Shimizu W; Yasutake M
    Int Heart J; 2016 Sep; 57(5):637-9. PubMed ID: 27593536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Podocyturia is significantly elevated in untreated vs treated Fabry adult patients.
    Trimarchi H; Canzonieri R; Schiel A; Politei J; Stern A; Andrews J; Paulero M; Rengel T; Aráoz A; Forrester M; Lombi F; Pomeranz V; Iriarte R; Young P; Muryan A; Zotta E
    J Nephrol; 2016 Dec; 29(6):791-797. PubMed ID: 26842625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel alpha-galactosidase a mutant (M42L) identified in a renal variant of Fabry disease.
    Rosenthal D; Lien YH; Lager D; Lai LW; Shang S; Leung N; Fervenza FC
    Am J Kidney Dis; 2004 Nov; 44(5):e85-9. PubMed ID: 15492942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure.
    Van Loo A; Vanholder R; Madsen K; Praet M; Kint J; De Paepe A; Messiaen L; Lameire N; Hasholt L; Sørensen SA; Ringoir S
    Am J Nephrol; 1996; 16(4):352-7. PubMed ID: 8739292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
    G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of Fabry's disease with granulomatous interstitial nephritis.
    Hiraizumi Y; Kanoh M; Shigematsu H; Yamashina M; Kondo T
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):655-61. PubMed ID: 8583703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpected Fabry disease in a renal allograft kidney: an underrecognized cause of poor allograft function.
    Kochar O; Wick MR; Kerr SE; Oglesbee D; Cathro HP
    Ultrastruct Pathol; 2011 Apr; 35(2):92-6. PubMed ID: 21299350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A family with a rare disease].
    Capelo J; Soares C; Carragoso A; Ribeiro P; Girão F; Henriques P
    Acta Med Port; 2010; 23(3):499-504. PubMed ID: 20654270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Biomarkers of Fabry Nephropathy: A Review of the Literature.
    Riccio E; Sabbatini M; Capuano I; Pisani A
    Nephron; 2019; 143(4):274-281. PubMed ID: 31614349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Painful fingers, heat intolerance, and telangiectases of the ear: easily ignored childhood signs of Fabry disease.
    Shelley ED; Shelley WB; Kurczynski TW
    Pediatr Dermatol; 1995 Sep; 12(3):215-9. PubMed ID: 7501549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.